Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Apr 7;8(4):37.
doi: 10.3390/jcdd8040037.

Lost but Not Lost-Embolization of a Leadless Pacemaker to the Pulmonary Artery with Consecutive Endovascular Recovery

Affiliations
Case Reports

Lost but Not Lost-Embolization of a Leadless Pacemaker to the Pulmonary Artery with Consecutive Endovascular Recovery

Fabian Barbieri et al. J Cardiovasc Dev Dis. .

Abstract

Background: Leadless transcatheter pacemaker systems (TPS) have become a valuable alternative to transvenous pacemakers in selected indications. With the steadily increasing amount of TPS implantations performed worldwide, reports of periprocedural complications are likewise increasingly found in the literature but are still underreported.

Case presentation: We report a case of a 75 year old male undergoing TPS implantation due to cardioinhibitory vasovagal syncope. The implantation was primarily uneventful; adequate pacing parameters and fixation of the device were achieved. Unfortunately, dislocation of the leadless pacemaker occurred at the end of the procedure and the device embolized into a primary side branch of the right pulmonary artery. Endovascular retrieval was performed by using a single snare technique without any further complications.

Conclusions: Although challenging, endovascular recovery of embolized TPS from the pulmonary artery is feasible and may be successfully accomplished by experienced implanters.

Keywords: case report; device embolization; pulmonary artery; transcatheter pacemaker system.

PubMed Disclaimer

Conflict of interest statement

Fabian Barbieri received grant support from Boston Scientific (St. Paul, MN, USA) and Abbott Laboratories paid to the Medical University of Innsbruck, as well as consulting fees from Boston Scientific.

References

    1. Brignole M., Auricchio A., Baron-Esquivias G., Bordachar P., Boriani G., Breithardt O.A., Cleland J., Deharo J.-C., Delgado V., Elliott P.M., et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA) Eur. Heart J. 2013;34:2281–2329. - PubMed
    1. Udo E.O., Zuithoff N.P., van Hemel N.M., de Cock C.C., Hendriks T., Doevendans P.A., Moons K.G. Incidence and predictors of short- and long-term complications in pacemaker therapy: The FOLLOWPACE study. Heart Rhythm. 2012;9:728–735. doi: 10.1016/j.hrthm.2011.12.014. - DOI - PubMed
    1. Semmler G., Barbieri F., Thudt K., Vock P., Mörtl D., Mayr H., Wollmann C.G., Adukauskaite A., Pfeifer B., Senoner T., et al. Long-Term Technical Performance of the Osypka QT-5® Ventricular Pacemaker Lead. J. Clin. Med. 2021;10:639. doi: 10.3390/jcm10040639. - DOI - PMC - PubMed
    1. Reynolds D., Duray G.Z., Omar R., Soejima K., Neuzil P., Zhang S., Narasimhan C., Steinwender C., Brugada J., Lloyd M., et al. A Leadless Intracardiac Transcatheter Pacing System. N. Engl. J. Med. 2016;374:533–541. doi: 10.1056/NEJMoa1511643. - DOI - PubMed
    1. Steinwender C., Khelae S.K., Garweg C., Chan J.Y.S., Ritter P., Johansen J.B., Sagi V., Epstein L.M., Piccini J.P., Pascual M., et al. Atrioventricular Synchronous Pacing Using a Leadless Ventricular Pacemaker: Results from the MARVEL 2 Study. JACC Clin. Electrophysiol. 2020;6:94–106. doi: 10.1016/j.jacep.2019.10.017. - DOI - PubMed

Publication types

LinkOut - more resources